Skip to content
+27 12 743 5959sales@xavant.com

NEWS

Facebook page opens in new windowX page opens in new windowLinkedin page opens in new windowYouTube page opens in new window
Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping
Developers of Quantitative TOF Monitors (NMT Monitors), Nerve Mapping and Locating devices.
Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping
  • Products
  • Videos
  • Online Courses
  • Support
  • About us
  • en_USEnglish
    • es_ESEspañol
    • de_DEDeutsch
  • Products
  • Videos
  • Online Courses
  • Support
  • About us
  • Contact
  • en_USEnglish
    • es_ESEspañol
    • de_DEDeutsch

Expand Your Knowledge and Earn CME Credits with Xavant's XPeer Medical Education

At Xavant Technology, we’re excited to help clinicians grow professionally. We are thrilled to share that our recent webinar course on Neuromuscular Block Monitoring is now available on the XPeer Medical Education platform. It provides you with an opportunity to expand your knowledge and earn Continuing Medical Education (CME) credits. In this article, we will break down which countries and credits are available through this online course.

EACCME Recognition Agreement

Our webinar course holds significant value. Why? Because it is accredited with 1 ECMEC credit, recognized in 26 countries. Here is a quick list: Armenia, Georgia, Malta, Slovakia, UK, Belgium, Greece, Netherlands, Slovenia, Bulgaria, Hungary, Norway, Spain, Croatia, Ireland, Poland, Sweden, Cyprus, Lombardia, Portugal, Tunisia, Austria, Finland, Luxembourg, Romania, and Turkey. If you’re a clinician in these countries, you’re in luck. The ECMEC credit gets recognized automatically, making everything smooth for you.

Voluntary Recognition and Other Regions

Now, let’s talk about other places. Even though the countries we listed earlier have formal agreements, many other European and Latin American countries also value our course credits. But remember, in these areas, credit recognition might be voluntary. So, if you’re a physician here, you might need to show your local entities how relevant our course is.

Recognition in the United States

Here is a simple guide to get the CME credits in the USA:

Step 1: Take the Course on XPeer

First, head over to the XPeer app (https://www.xpeer.app/). Pick the course you like, finish it, and grab that diploma with 1 ECMEC credit. XPeer offers a wide range of accredited courses from renowned experts, ensuring high-quality educational content.

Step 2: Visit the AMA-UEMS Agreement

Got the diploma? Great! Now, go to the AMA-UEMS Agreement page (https://www.ama-assn.org/education/ama-pra-credit-system/agreement-european-union-medical-specialties-uems). This page will tell you how to change your ECMEC credits into AMA PRA Category 1 Credits.

Step 3: International Credit Conversion Request

Next, click on this link to visit the US accrediting website (https://edhub.ama-assn.org/pages/applications). Here, you can submit an international credit conversion request. Just a heads up, this might cost you $75.

Step 4: Convert ECMEC to AMA PRA Category 1 Credit

Simply follow the steps on the website. Give them all the details they need, including your new ECMEC credit info. Once they give you the green light, you’ll get 1 AMA PRA Category 1 Credit.

About XPeer

XPeer Medical Education is an innovative platform that offers a comprehensive range of educational resources for medical professionals. It serves as a hub for healthcare providers to access high-quality courses, webinars, and educational materials. Xavant Technology is proud to collaborate with XPeer Medical Education to deliver our accredited webinar course, providing clinicians with a convenient and trusted platform to expand their knowledge and earn CME credits.

About Xavant Technology

Xavant Technology provides educational material through the “Behind the Mask” initiative. By participating in our webinar course available on XPeer Medical Education, clinicians can expand their knowledge and also earn valuable CME credits. With recognition agreements in multiple countries and the support of XPeer Medical Education, we are committed to providing healthcare professionals with accessible and high-quality educational opportunities. Take advantage of this exciting opportunity to enhance your professional growth and stay at the forefront of medical advancements.

Note: The information provided in this article is subject to change, and it is recommended to consult with local entities or regulatory bodies for the most up-to-date information regarding CME credit recognition in specific countries or regions.

By Xavant TechnologyAugust 20, 2023

Related Articles

ASA San Francisco October 2023
October 8, 2023
ANZCA (ICC Sydney, 5-9 May 2023)
May 1, 2023
V10.5 Software Released!
May 1, 2023
DAC (Dusseldorf, 27-29 April 2023)
April 23, 2023
Vienna Anesthesia Days 2023 (Vienna, 27-29 April 2023)
April 23, 2023
IFIMP (Innsbruck, 26-27 April 2023)
April 21, 2023
We are leading suppliers of quantitative NMT and TOF monitors for use during general anaesthesia, and peripheral nerve stimulators with nerve mapping and locating for optimal peripheral nerve blocks during regional anaesthesia.
Follow Us
Linkedin-in Youtube
Stay Connected
Join us as we strive to eliminate Residual Neuromuscular Block. Get all the latests products updates and educational tools to achieve this goal in your practice.
Navigate
Menu
  • Distributors
  • Integration Partner
  • Online Courses
  • Blog
  • Support
  • Certificates
  • About us
  • Contact Us
Xavant Technology (Pty) Ltd Unit 102 The Tannery Industrial Park 309 Derdepoort Ave Silverton, Pretoria, South Africa 0184
Privacy Policy | About
Copyright 2023. All rights reserved.

The Stimpod NMS450X+, equipped with two different modalities (AMG and EMG), empowers anaesthesiologists to achieve safer intraoperative control of patients’ neuromuscular blockade. The full case NMT Monitoring enables safe extubation and eliminate residual paralysis in any hospital setting, provider preference and surgery type. This advanced technology empowers clinicians to have a safer and more precise control over the neuromuscular blockade during surgery, aligning with the latest guideline-concordant recommendations for the monitoring of patients for residual paralysis following the administration of a neuromuscular reversal agent. The ASA and ESAIC strongly recommend the use of a quantitative neuromuscular blocking agent monitor in conjunction with neuromuscular blocking agents.

While reversal drugs like Sugammadex are commonly used for NMBA reversal, they are not a foolproof solution and residual paralysis remains a significant concern based on clinical evidence. By incorporating the Stimpod NMS450X+ into their practice, anaesthesiologists can proactively monitor the depth of neuromuscular blockade, significantly reducing the incidence of residual paralysis in patients. This contributes to improved patient outcomes and a safer post-operative recovery.

The Stimpod NMS450X+ offers a cost-effective solution in the OR, PACU and ICU. With its two modalities, AMG and EMG, the device provides flexibility in monitoring options. The only neuromuscular monitoring system available with both AMG and EMG enabling cost control at the point-of-care based on need and specific setting, allowing affordable standardisation across the entire hospital. Cost of Care model, enabling monitoring of all drug usage to ensure optimal use, thus saving on both paralytic and recovery agents. This cost-saving feature ensures efficient resource management without compromising patient safety.

AMG offers the most cost-effective option to implement with a reusable sensor and versatile patient setup options enabling neuromuscular transmission monitoring of the hand, toe or face.

EMG is ideally suited for neuromuscular monitoring of surgeries where tucked hands and arms are required, with optimised performance through a patented, skin-like electrode.

Residual neuromuscular blockade after anaesthesia has been linked to severe complications and adverse outcomes, including increased oxygen desaturation, postoperative pneumonia, airway obstruction, and reintubation. By utilizing the Stimpod NMS450X+ and effectively preventing residual NMB, clinicians can contribute to reduced LOS in hospitals and improve patient recovery rates.

Anaesthesiologists worldwide who have adopted the Stimpod NMS450X+ demonstrate their commitment to following the latest guidelines and best practices in anaesthesia. By incorporating a quantitative NMBA monitor into their practice, clinicians align themselves with the recommendations set forth by the ASA and ESAIC, promoting a higher standard of care and patient safety. By utilizing the Stimpod NMS450X+, anaesthesiologists are a testament to its effectiveness to improve patients outcomes and can contribute to the reduction of adverse events and enhance the recovery process for their patients.

This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.I agreeCookie policy